Desquinolinyl Lenvatinib CAS 796848-79-8 Ubunyulu >99.0% (HPLC) Lenvatinib Mesylate Intermediate Factory

Inkcazelo emfutshane:

1-(2-Chloro-4-Hydroxyphenyl)-3-Cyclopropylurea

Izithethantonye: Desquinolinyl Lenvatinib

I-CAS: 796848-79-8

Ubunyulu: >99.0% (HPLC)

Imbonakalo: Okumhlophe-kuMhlophe ukuya kuBomvu oBrown obuqinileyo obuqinileyo

Umbindi weLenvatinib Mesylate CAS 857890-39-2

E-Mail: alvin@ruifuchem.com


Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

Iipropati zeMichiza:

Igama leMchiza 1-(2-Chloro-4-Hydroxyphenyl)-3-Cyclopropylurea
Izithethantonye I-Desquinolinyl Lenvatinib;Ukungcola kweLenvatinib 16;Ukungcola kweLenvatinib Desquinolinyl;Ukungcola kweLenvatinib LFS-A;ILenvatinib Mesylate ePhakathi Ⅲ;N-(2-Chloro-4-Hydroxyphenyl)-N'-Cyclopropyl-Urea
Inombolo yeCAS 796848-79-8
Inombolo yeCAT RF-PI1972
Ubume beStokhwe Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni
Ifomula yeemolekyuli I-C10H11ClN2O2
Ubunzima beMolekyuli 226.66
Indawo yokubilisa 364.6±42.0℃
Ukuxinana 1.43±0.10 g/cm3
Uphawu Ruifu Chemical

Iinkcukacha:

Into Iinkcukacha
Imbonakalo I-Off-White ukuya kuBomvu obumdaka obumdaka obuqinileyo
Ubunyulu / Indlela yokuHlalutya >99.0% (HPLC)
Ukufuma (KF) <0.50%
Intsalela kwi-Ignition <0.20%
Ukungacoceki Okukodwa <0.50%
Ukungcola ngokupheleleyo <1.00%
Iintsimbi ezinzima <10ppm
I-Infrared Spectrum Iyahambelana noLwakhiwo
NMR Iyahambelana noLwakhiwo
Umgangatho woVavanyo Umgangatho woShishino
Ukusetyenziswa Umbindi weLenvatinib Mesylate (CAS: 857890-39-2)

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi

Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma

Izinto eziluncedo:

1

FAQ:

Isicelo:

I-1-(2-Chloro-4-Hydroxyphenyl) -3-Cyclopropylurea, eyaziwa nangokuthi i-Desquinolinyl Lenvatinib, (i-CAS: 796848-79-8) iphakathi okanye ukungcola kweLenvatinib Mesylate (CAS: 857890-39-2).I-Desquinolinyl Lenvatinib yi-metabolite ye-Lenvatinib Mesylate eyi-inhibitor esebenzayo yomlomo ye-multiple receptor tyrosine kinases kuquka i-VEGF, i-FGF kunye ne-SCF receptors.I-Lenvatinib lichiza elichasayo lomhlaza kunyango lweentlobo ezithile zomhlaza wegilo, kwaye kunokwenzeka nakwezinye ii-cancer.Ngomhla we-13 kaFebruwari, i-2015, i-US FDA ivume i-anticancer drug Lenvatinib kunyango lomhlaza we-thyroid.I-Lenvatinib yi-inhibitor ye-enzyme ejoliswe kwizinto ezininzi, ekwazi ukuthintela i-VEGFR2 kunye ne-VEGFR3 (i-vascular endothelial growth factor receptor).Igama lezorhwebo leLenvatinib yiLenvima.

Bhala umyalezo wakho apha kwaye uwuthumele kuthi